期刊
BLOOD
卷 123, 期 14, 页码 2181-2188出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2013-08-523563
关键词
-
类别
资金
- Austrian Science Fund FWF [SFB-P021, P25015-B13]
- Paracelsus Medical University Salzburg [PMU-FFF E-12/15/074-HAH, E-10/11/058-HAR]
- Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research GmbH
- province of Salzburg
- Austrian Science Fund (FWF) [P 25015, T 671] Funding Source: researchfish
- Austrian Science Fund (FWF) [T671, W1213, P25015] Funding Source: Austrian Science Fund (FWF)
Signals from the tumor microenvironment promote the migration, survival, and proliferation of chronic lymphocytic leukemia (CLL) cells. Rho GTPases control various signaling pathways downstream of microenvironmental cues. Here, we analyze the function of Rac1 in the motility and proliferation of CLL cells. We found decreased transcription of the Rac guanine nucleotide exchange factors Tiam1 and Vav1 in un-stimulated peripheral blood CLL cells with almost complete loss of Tiam1 but increased transcription of the potential Rac antagonist RhoH. Consistently, stimulation of CLL cells with the chemokine CXCL12 induced RhoA but not Rac1 activation, whereas chemokine-induced CLL cell motility was Rac1-independent. Coculture of CLL cells with activated T cells induced their activation and subsequent proliferation. Here, Tiam1 expression was induced in the malignant cells in line with increased Ki-67 and c-Myc expression. Rac1 or Tiam1 knockdown using siRNA or treatment with the Tiam1/Rac inhibitor NSC-23766 attenuated c-Myc transcription. Furthermore, treatment of CLL cells with NSC-23766 reduced their proliferation. Rac inhibition also antagonized the chemoresistance of activated CLL cells toward fludarabine. Collectively, our data suggest a dynamic regulation of Rac1 function in the CLL microenvironment. Rac inhibition could be of clinical use by selectively interfering with CLL cell proliferation and chemoresistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据